TY - JOUR
T1 - Radiation-induced heart disease after treatment for esophageal cancer
AU - Jingu, Keiichi
AU - Umezawa, Rei
AU - Fukui, Katsuya
N1 - Publisher Copyright:
© 2017, The Japan Esophageal Society and Springer Japan.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Recently, the development of radiotherapy technology and to radiation-induced heart disease in patients with esophageal cancer. Investigations using chemotherapy has improved treatment results for esophageal cancer, and attention has been paidSEER for esophageal cancer showed that the hazard ratio of heart-related death was 1.62–1.96. Herein we review published literature regarding the mechanism of and countermeasures for radiation-induced heart disease and discuss the potential of concurrent chemotherapy, molecular-targeted agents and lifestyle for exacerbating radiation-induced heart disease.
AB - Recently, the development of radiotherapy technology and to radiation-induced heart disease in patients with esophageal cancer. Investigations using chemotherapy has improved treatment results for esophageal cancer, and attention has been paidSEER for esophageal cancer showed that the hazard ratio of heart-related death was 1.62–1.96. Herein we review published literature regarding the mechanism of and countermeasures for radiation-induced heart disease and discuss the potential of concurrent chemotherapy, molecular-targeted agents and lifestyle for exacerbating radiation-induced heart disease.
KW - Molecular-targeted agent
KW - Radiation-induced arrhythmia
KW - Radiation-induced heart disease
KW - Radiation-induced myocardial disease
UR - http://www.scopus.com/inward/record.url?scp=85008671037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008671037&partnerID=8YFLogxK
U2 - 10.1007/s10388-017-0569-5
DO - 10.1007/s10388-017-0569-5
M3 - Article
AN - SCOPUS:85008671037
SN - 1612-9059
VL - 14
SP - 215
EP - 220
JO - Esophagus
JF - Esophagus
IS - 3
ER -
